Alector Company
Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel.
Investors
Headquarters:
San Francisco, California, United States
Number Of Exists:
101-250
Total Funding:
194500000
Founded Date:
2013-01-01
Employee Number:
101-250
Last Funding Type:
Series E
Investors Number:
20
Last Funding Date:
2018-07-25
Funding Status:
IPO
Estimated Revenue:
$10M to $50M
Industry:
Neurodegeneration and aging